Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Zhangjiang Hi-Tech Park Buys Stake in Buchang Pharma

publication date: Sep 28, 2009
Zhangjiang Hi-Tech Park Development Co. of Shanghai will invest another 48 million RMB ($7 million) in its venture capital subsidiary, Haocheng Venture Capital Co. so that Haocheng can purchase a .4% stake in Shandong Buchang Pharmaceutical Co. Zhangjiang will purchase the shares from Shenzhen China Euro Capital Co. They carry a provision requiring Shenzhen China Euro to take back the shares if Buchang Pharma does not list its shares by the end of 2013. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital